𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin

✍ Scribed by P. Calsou; B. Salles


Publisher
Springer
Year
1993
Tongue
English
Weight
918 KB
Volume
32
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


v-src induces cisplatin resistance by in
✍ Naoko Masumoto; Shuji Nakano; Hiromitsu Fujishima; Kimitoshi Kohno; Yoshiyuki Ni πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 133 KB πŸ‘ 1 views

Activation of Src, which has an intrinsic protein tyrosine kinase (PTK) activity, has been demonstrated in human solid tumors, such as colorectal and breast cancers. To investigate the role of activated Src in drug resistance, we evaluated the effect of v-src on the resistance to various anti-cancer

Mechanism of resistance to cisplatin in
✍ Faina Vikhanskaya; Luana Clerico; Monica Valenti; Maria S. Stanzione; Massimo Br πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 99 KB πŸ‘ 2 views

A possible novel mechanism of cross-resistance to cisplatin (CDDP) in the doxorubicin-resistant ovarian-cancer cell line A2780-DX3, which displays atypical multidrug resistance, is presented. A2780-DX3 is found to be more resistant than the parental line A2780 in terms of CDDP-induced cytotoxicity a

Acquired resistance of melanoma cells to
✍ Markus Christmann; Matthias Pick; Hermann Lage; Dirk Schadendorf; Bernd Kaina πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 172 KB

Acquired resistance to antineoplastic agents is a frequent obstacle in tumor therapy. Malignant melanoma cells are particularly well known for their unresponsiveness to chemotherapy; only about 30% of tumors exhibit a transient clinical response to treatment. In our study, we investigated the molecu